Warner-Chilcott Back On The Block: Buy-Out Offer Values Firm At $2.7 Bil.
Private equity group has approached company about possible bid. Proposal comes a year after Warner-Chilcott/Galen held negotiations with another pharma company about a merger.
Private equity group has approached company about possible bid. Proposal comes a year after Warner-Chilcott/Galen held negotiations with another pharma company about a merger.